Pulmonx Corporation (LUNG)

NASDAQ: LUNG · Real-Time Price · USD

2.020

+0.410 (25.47%)

At close: Mar 6, 2026, 4:00 PM EST

2.000

-0.020 (-0.99%)

After-hours: Mar 6, 2026, 7:59 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Medical Products	90.50M	83.79M	68.68M	53.66M	48.42M
Medical Products Growth	8.01%	22.01%	27.98%	10.84%	47.91%
Total	90.50M	83.79M	68.68M	53.66M	48.42M
Total Growth	8.01%	22.01%	27.98%	10.84%	47.91%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	57.02M	56.47M	45.92M	32.49M	24.99M
United States Growth	0.99%	22.97%	41.34%	29.99%	54.37%
International	33.47M	-	-	-	-
Europe, Middle-East and Africa (EMEA)	-	22.33M	19.34M	-	-
Europe, Middle-East and Africa (EMEA) Growth	-	15.48%	-	-	-
Asia Pacific	-	4.44M	3.02M	2.87M	3.41M
Asia Pacific Growth	-	46.84%	5.48%	-16.05%	27.06%
Other International	-	556.00K	399.00K	155.00K	128.00K
Other International Growth	-	39.35%	157.42%	21.09%	161.22%
Europe, Middle-East and Africa (EMEA) Exclu. Germany	-	-	-	16.16M	-
Germany	-	-	-	2.00M	5.81M
Germany Growth	-	-	-	-65.63%	4.41%
Europe, Middle-East and Africa (EMEA) Exclu. Germany and France	-	-	-	-	9.72M
France	-	-	-	-	4.36M
Total	90.50M	83.79M	68.68M	53.66M	48.42M
Total Growth	8.01%	22.01%	27.98%	10.84%	47.91%

Source: S&P Global Market Intelligence.